-
Je něco špatně v tomto záznamu ?
Position paper for the organization of ECMO programs for cardiac failure in adults
D. Abrams, AR. Garan, A. Abdelbary, M. Bacchetta, RH. Bartlett, J. Beck, J. Belohlavek, YS. Chen, E. Fan, ND. Ferguson, JA. Fowles, J. Fraser, M. Gong, IF. Hassan, C. Hodgson, X. Hou, K. Hryniewicz, S. Ichiba, WA. Jakobleff, R. Lorusso, G....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- dospělí MeSH
- kardiogenní šok * MeSH
- lidé MeSH
- mimotělní membránová oxygenace * MeSH
- podpůrné srdeční systémy MeSH
- srdeční selhání * terapie MeSH
- transplantace srdce MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.
Critical Care Department Cairo University Cairo Egypt
Department of Anaesthesia and Intensive Care Papworth Hospital NHS Foundation Trust Cambridge UK
Department of Cardiology Fundación Cardiovascular de Colombia Bucaramanga Colombia
Department of Emergency Medicine Teikyo University Hospital Tokyo Japan
Department of Internal Medicine 2 University Hospital of Regensburg Regensburg Germany
Department of Surgery Columbia University Medical Center New York NY USA
Department of Surgery National Taiwan University Hospital Taipei Taiwan
Department of Surgery University of Michigan Ann Arbor MI USA
Department of Surgical Intensive Care Medicine Nippon Medical School Hospital Tokyo Japan
Division of Cardiac Vascular and Thoracic Surgery Columbia University Medical Center New York NY USA
Division of Cardiology Columbia University Medical Center New York NY USA
Division of Pediatric Cardiology Columbia University Medical Center New York NY USA
Hamad Medical Corporation Weill Cornell Medical College in Qatar Doha Qatar
Intensive Care Unit The Alfred Hospital Melbourne Australia
Minneapolis Heart Institute Abbott Northwestern Hospital Minneapolis MN USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012831
- 003
- CZ-PrNML
- 005
- 20210305120437.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00134-018-5064-5 $2 doi
- 035 __
- $a (PubMed)29450594
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Abrams, Darryl $u Division of Pulmonary, Allergy, and Critical Care, Columbia University College of Physicians and Surgeons/NewYork-Presbyterian Hospital, 622 W168th St, PH 8E, Room 101, New York, NY, 10032, USA.
- 245 10
- $a Position paper for the organization of ECMO programs for cardiac failure in adults / $c D. Abrams, AR. Garan, A. Abdelbary, M. Bacchetta, RH. Bartlett, J. Beck, J. Belohlavek, YS. Chen, E. Fan, ND. Ferguson, JA. Fowles, J. Fraser, M. Gong, IF. Hassan, C. Hodgson, X. Hou, K. Hryniewicz, S. Ichiba, WA. Jakobleff, R. Lorusso, G. MacLaren, S. McGuinness, T. Mueller, PK. Park, G. Peek, V. Pellegrino, S. Price, EB. Rosenzweig, T. Sakamoto, L. Salazar, M. Schmidt, AS. Slutsky, C. Spaulding, H. Takayama, K. Takeda, A. Vuylsteke, A. Combes, D. Brodie, . ,
- 520 9_
- $a Extracorporeal membrane oxygenation (ECMO) has been used increasingly for both respiratory and cardiac failure in adult patients. Indications for ECMO use in cardiac failure include severe refractory cardiogenic shock, refractory ventricular arrhythmia, active cardiopulmonary resuscitation for cardiac arrest, and acute or decompensated right heart failure. Evidence is emerging to guide the use of this therapy for some of these indications, but there remains a need for additional evidence to guide best practices. As a result, the use of ECMO may vary widely across centers. The purpose of this document is to highlight key aspects of care delivery, with the goal of codifying the current use of this rapidly growing technology. A major challenge in this field is the need to emergently deploy ECMO for cardiac failure, often with limited time to assess the appropriateness of patients for the intervention. For this reason, we advocate for a multidisciplinary team of experts to guide institutional use of this therapy and the care of patients receiving it. Rigorous patient selection and careful attention to potential complications are key factors in optimizing patient outcomes. Seamless patient transport and clearly defined pathways for transition of care to centers capable of providing heart replacement therapies (e.g., durable ventricular assist device or heart transplantation) are essential to providing the highest level of care for those patients stabilized by ECMO but unable to be weaned from the device. Ultimately, concentration of the most complex care at high-volume centers with advanced cardiac capabilities may be a way to significantly improve the care of this patient population.
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a mimotělní membránová oxygenace $7 D015199
- 650 12
- $a srdeční selhání $x terapie $7 D006333
- 650 _2
- $a transplantace srdce $7 D016027
- 650 _2
- $a podpůrné srdeční systémy $7 D006353
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kardiogenní šok $7 D012770
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Garan, A Reshad $u Division of Cardiology, Columbia University Medical Center, New York, NY, USA.
- 700 1_
- $a Abdelbary, Akram $u Critical Care Department, Cairo University, Cairo, Egypt.
- 700 1_
- $a Bacchetta, Matthew $u Department of Surgery, Columbia University Medical Center, New York, NY, USA.
- 700 1_
- $a Bartlett, Robert H $u Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
- 700 1_
- $a Beck, James $u Clinical Perfusion & Anesthesia Support Services, New York Presbyterian Hospital, Columbia University Medical Center, Morgan Stanley Children's Hospital of New York, New York, NY, USA.
- 700 1_
- $a Belohlavek, Jan $u Second Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Chen, Yih-Sharng $u Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
- 700 1_
- $a Fan, Eddy $u Interdepartmental Division of Critical Care Medicine, Departments of Medicine and Physiology, Institute for Health Policy, Management, and Evaluation, University of Toronto Research Institute, Toronto, Canada. Extracorporeal Life Support Program, Toronto General Hospital, Toronto, Canada.
- 700 1_
- $a Ferguson, Niall D $u Interdepartmental Division of Critical Care Medicine, Departments of Medicine and Physiology, Institute for Health Policy, Management, and Evaluation, University of Toronto Research Institute, Toronto, Canada. Division of Respirology, Department of Medicine, University Health Network and Sinai Health System, Toronto General Hospital, Toronto, Canada.
- 700 1_
- $a Fowles, Jo-Anne $u Department of Anaesthesia and Intensive Care, Papworth Hospital NHS Foundation Trust, Cambridge, UK. $7 xx0257918
- 700 1_
- $a Fraser, John $u Adult Intensive Care Service, The Prince Charles Hospital and University of Queensland, Brisbane, Australia.
- 700 1_
- $a Gong, Michelle $u Division of Critical Care Medicine, Department of Medicine, Jay B. Langner Critical Care Service, Montefiore Medical Center, New York, NY, USA.
- 700 1_
- $a Hassan, Ibrahim F $u Hamad Medical Corporation, Weill Cornell Medical College in Qatar, Doha, Qatar.
- 700 1_
- $a Hodgson, Carol $u Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia. Physiotherapy Department, The Alfred Hospital, Melbourne, Australia.
- 700 1_
- $a Hou, Xiaotong $u Center for Cardiac Intensive Care, Capital Medical University Affiliated Anzhen Hospital, Beijing, People's Republic of China.
- 700 1_
- $a Hryniewicz, Katarzyna $u Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, USA.
- 700 1_
- $a Ichiba, Shingo $u Department of Surgical Intensive Care Medicine, Nippon Medical School Hospital, Tokyo, Japan.
- 700 1_
- $a Jakobleff, William A $u Department of Cardiothoracic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.
- 700 1_
- $a Lorusso, Roberto $u Cardiothoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.
- 700 1_
- $a MacLaren, Graeme $u Cardiothoracic ICU, National University Health System, Singapore, Singapore. Paediatric ICU, Royal Children's Hospital, Melbourne, Australia.
- 700 1_
- $a McGuinness, Shay $u Cardiothoracic and Vascular ICU, Auckland City Hospital, Auckland, New Zealand. Medical Research Institute of New Zealand, Wellington, New Zealand. Australia and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
- 700 1_
- $a Mueller, Thomas $u Department of Internal Medicine II, University Hospital of Regensburg, Regensburg, Germany.
- 700 1_
- $a Park, Pauline K $u Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
- 700 1_
- $a Peek, Giles $u Department of Cardiothoracic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.
- 700 1_
- $a Pellegrino, Vin $u Intensive Care Unit, The Alfred Hospital, Melbourne, Australia.
- 700 1_
- $a Price, Susanna $u Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, London, UK.
- 700 1_
- $a Rosenzweig, Erika B $u Division of Pediatric Cardiology, Columbia University Medical Center, New York, NY, USA.
- 700 1_
- $a Sakamoto, Tetsuya $u Department of Emergency Medicine, Teikyo University Hospital, Tokyo, Japan.
- 700 1_
- $a Salazar, Leonardo $u Department of Cardiology, Fundación Cardiovascular de Colombia, Bucaramanga, Colombia.
- 700 1_
- $a Schmidt, Matthieu $u Medical-Surgical Intensive Care Unit, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75013, Paris, France. INSERM, Institute of Cardiometabolism and Nutrition UMRS_1166-ICAN, Sorbonne University Paris, Paris, France.
- 700 1_
- $a Slutsky, Arthur S $u Keenan Research Center, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada. Interdepartmental Division of Critical Care Medicine, Department of Medicine, University of Toronto, Toronto, Canada.
- 700 1_
- $a Spaulding, Christian $u Department of Cardiology, European Hospital Georges Pompidou, Assistance Publique Hôpitaux de Paris and Sudden Death Expert Center, INSERM U 905, Paris Descartes University, Paris, France.
- 700 1_
- $a Takayama, Hiroo $u Division of Cardiac, Vascular and Thoracic Surgery, Columbia University Medical Center, New York, NY, USA.
- 700 1_
- $a Takeda, Koji $u Division of Cardiac, Vascular and Thoracic Surgery, Columbia University Medical Center, New York, NY, USA.
- 700 1_
- $a Vuylsteke, Alain $u Department of Anaesthesia and Intensive Care, Papworth Hospital NHS Foundation Trust, Cambridge, UK.
- 700 1_
- $a Combes, Alain $u Medical-Surgical Intensive Care Unit, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75013, Paris, France. INSERM, Institute of Cardiometabolism and Nutrition UMRS_1166-ICAN, Sorbonne University Paris, Paris, France.
- 700 1_
- $a Brodie, Daniel $u Division of Pulmonary, Allergy, and Critical Care, Columbia University College of Physicians and Surgeons/NewYork-Presbyterian Hospital, 622 W168th St, PH 8E, Room 101, New York, NY, 10032, USA. hdb5@cumc.columbia.edu.
- 700 1_
- $a ,
- 773 0_
- $w MED00002258 $t Intensive care medicine $x 1432-1238 $g Roč. 44, č. 6 (2018), s. 717-729
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29450594 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20210305120351 $b ABA008
- 999 __
- $a ok $b bmc $g 1392141 $s 1051136
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 44 $c 6 $d 717-729 $e 20180215 $i 1432-1238 $m Intensive care medicine $n Intensive Care Med $x MED00002258
- LZP __
- $a Pubmed-20190405